MERCK & CO., INC. (MRK)
Clinical trial NCT06162663 updates: 1. primary completion date: 2026-02-17 → 2026-01-15 2. enrollment: 5 → 6 participants
Clinical trial NCT06162663 updates: 1. primary completion date: 2026-02-17 → 2026-01-15 2. enrollment: 5 → 6 participants
📉 **NEGATIVE** • Medium confidence analysis (62%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (24%) **Content type:** Clinical